Email This Article
Headlines & Perspectives
Biotech Mailbag: Savient's Unsavory Surprise
By
Adam Feuerstein
10/31/08 - 03:19 PM EDT
Savient Pharmaceuticals on Monday released new safety data linking its gout drug Puricase to serious cardiovascular side effects.
The information entered on this page will not be used to send unsolicited email and will not be sold to a 3rd party.
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,449.74 | 1,114.90 | 2,235.52 | 36.13 |
Oil *
74.18
|
|
UP
120.85
|
UP
12.43
|
UP
23.83
|
UP
0.67
|
10 Yr
3.61%
SPDR Gold
108.35
|
|
+1.17%
|
+1.13%
|
+1.08%
|
+1.89%
|
Data delayed 20 minutes |
Connect with TheStreet